Whereas ER-α drives proliferation of mammary epithelial cells, implying a valid therapeutic target, ER-β is associated with differentiation of normal breast cells [32], mediates the preventive benefits of exercise and parity [33] on breast cancer incidence, and may directly inhibit breast cancer progression [34]. This evidence concerns the gene ESR2 and breast cancer.